The objective of the current study was to investigate the genetics of antibody responses to an acellular pertussis vaccine by a genomewide association study in mice. Female mice of 28 inbred strains received this vaccine at 6, 8, and 12 weeks of age. The antibody titer and avidity of immunoglobulin (Ig) G specific for diphtheria toxin, pertussis toxin, filamentous hemagglutinin and pertactin were measured at 14 and 24 weeks of age. The magnitude, longevity and avidity of IgG differed significantly among mouse strains. There was significant correlation between antigen-specific IgGs for longevity but not for magnitude and avidity. Association mapping and analysis with PolyPhen software identified 6 genetic markers associated with longevity for all 4 antigens, although the expression levels of these genes did not correlate with longevity phenotype. This study provides novel insights into the genetic basis and potential candidate genes for differences in the IgG responses to vaccination.
The introduction of vaccines against pertussis in the 1940s dramatically reduced the incidence of the disease. The original vaccine consisted of killed whole bacterial cells added to inactivated diphtheria and tetanus toxins combined with aluminum adjuvant. The whole-cell pertussis vaccine was replaced in the 1990s by 1 or more bacterial components as an acellular pertussis (diphtheria, tetanus and acellular pertussis [DTaP] ) vaccine, which reduced the vaccine's reactogenicity. Over the past 15 years, the incidence of pertussis has steadily increased despite high rates of vaccination in infants and children. Epidemiologic studies have shown that the incidence of pertussis was lower in individuals vaccinated with the original vaccine than in those who received the DTaP vaccine [1] [2] [3] . In addition, the age at which pertussis occurs has increased, with a greater proportion of cases in teenagers and adults [4] . These studies point to a reduced longevity of the protective immunity induced by the DTaP vaccine.
The magnitude, longevity, and avidity of the antibody response to pertussis vaccination vary widely among individuals [4] [5] [6] . Both genetic and nongenetic factors-such as age, nutrition, and health status-underlie the divergent immune responses to vaccination. Studies of monozygotic and dizygotic twins have estimated the heritability of antibody titers to different childhood vaccines at 44%-88.5% [7, 8] . Findings of twin studies suggested that environmental factors rather than genetics affect the duration of immunity and avidity of the immune response to tetanus toxoid vaccination [9] , but this remains to be determined for other diseases.
Attempts to identify genes involved in the immune response to vaccines have relied mostly on candidate gene approaches. These studies revealed significant associations between polymorphisms in major histocompatibility complex, cytokine, innate immunity and virus receptor genes, and immune responses induced by hepatitis B, measles, and rubella vaccination [10, 11] . However, to identify genes not previously associated with immune responses, unbiased genome-wide association studies (GWASs) are necessary. Such studies require a large number of subjects when conducted in humans. An alternative approach takes advantage of the availability of well-characterized inbred strains of mice and increasingly sophisticated bioinformatics tools. These methods have been successfully used to identify genes associated with human disease, including blood plasma levels of high-density lipoprotein and asthma [12, 13] . In the current study, we applied this approach to study the genetic variability of antibody responses to vaccination with DTaP.
METHODS

Mice
Eight female mice (5 weeks old) from 28 different inbred strains (Supplementary Table 1 ) (Jackson Laboratory) were housed (4 mice per box) in ventilated racks with a 12-hour-light/12-hourdark cycle and ad lib access to water and chow. The mice were injected intramuscularly with 50 µL of DTaP vaccine at 6, 8, and 12 weeks of age in alternating hind legs. Blood samples were collected at 14 and 24 weeks of age. The experimental protocol was approved by the Purdue University Animal Care and Use Committee.
Vaccine
The vaccine was a DTaP vaccine, Infanrix (GlaxoSmithKline), containing diphtheria toxoid (DT), tetanus toxoid, pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (Prn), and aluminum hydroxide adjuvant.
Serology by Enzyme-Linked Immunosorbent Assay
Microtiter plates were coated with 2 µg/mL DT, PT, FHA, and Prn (List Biological) and washed with phosphate-buffered saline/0.05% Tween 20 (PBST). Wells were blocked with 1% bovine serum albumin in PBST and incubated with serum followed by horseradish peroxidase-conjugated secondary antibody (Sigma) and tetramethylbenzidine substrate (Sigma). The reaction was stopped with 2N sulfuric acid, and the optical density (OD) was read at 450 nm (BioTek). Serum from BALB/ cJ mice hyperimmunized with DTaP was pooled and used to develop a standard curve in each plate. The titer of the hyperimmune serum was set at 100 000 U/mL. Antibody titers less than the cutoff (≤800 U/mL) were assigned a titer of 400 U/ mL. Antibody magnitude measured at week 14 was presented after log 10 transformation, and antibody longevity was calculated as log 10 ratio of IgG titers (titer week 24/titer week 14). The same enzyme-linked immunosorbent assay (ELISA) was used to determine avidity, except that, after incubation with serum, each well was incubated with or without 6 mol/L urea (Sigma) at 37°C for 10 minutes. Data were presented as an avidity index (percentage), calculated as OD (urea)/OD (no urea) × 100.
Genetic Association Mapping
We tested for associations between the magnitude, longevity, and avidity of the antibody response against each of the 4 antigens (DT, PT, FHA, and Prn) and 4 million single-nucleotide polymorphisms (SNPs) published by the National Institute of Environmental Health Sciences, using the genome-wide efficient mixed-model association (GEMMA) algorithm [14, 15] . GEMMA analysis gives results identical to those of efficient mixed-model association (EMMA) but is approximately n times faster, where n is the sample size. GEMMA analysis, like that of EMMA, accounts for the different degrees of relatedness among inbred mouse strains and allows for the inclusion of wild-derived strains, such as CAST/EiJ and PWK/PhJ. Association testing excluded the C3H/HeOuJ strain because this strain has not been independently genotyped. When published, these SNPs were aligned to the mouse genome browser NCBI37/mm9, and this is reflected in all genomic locations reported herein.
Identification of Candidate Genes
To identify candidate genes, we identified all genes within 1 million base pairs of each of the top 200 most significantly associated variants for each phenotype. All nonsynonymous variants (missense, frameshift, and stop-gained) of each of these candidate genes were downloaded from Ensembl Biomart, along with affected protein sequences. PolyPhen-2 software (http://genetics.bwh.harvard.edu/pph2/) was used to predict the possible functional impact of each of these nonsynonymous mutations. Genes containing a variant with a PolyPhen score between 0.95 and 1 (predicted as "probably damaging") were retained as candidate genes. Venn diagrams (Venny 2.1 software; http:// bioinfogp.cnb.csic.es/tools/venny/index.html) were applied to demonstrate the number of overlapping genes shared by the vaccine antigens.
Expression of Candidate Genes for Longevity by Quantitative Reverse Transcription Polymerase Chain Reaction
The expression of candidate genes was compared in selected mouse strains using quantitative reverse transcription polymerase chain reaction (RT-qPCR). Twelve female BALB/cJ, 129S1/SvlmJ, SJL/J, and LP/J mice were vaccinated 3 times as described. After 1 and 7 days, draining (iliac) and nondraining (axillary) lymph nodes were collected and stored in RNAlater solution (Life Technologies). Total RNA was extracted using a Quick-RNA MiniPrep Plus kit (Zymo Research) with proteinase K and DNase І digestion. The mean (standard error of the mean) 260/280 ratio of RNA from all axillary and iliac lymph nodes was 2.030 (0.048). Total RNA of 1 µg was used for complementary DNA (cDNA) synthesis with an iScript cDNA Synthesis Kit (Bio-Rad) containing a blend of oligo dT/ random hexamer primers and using a Mastercycler Pro thermocycler (Eppendorf) with the following protocol: 25°C for 5, 46°C for 20, and 95°C for 1 minute. The interference of genomic DNA carryover in RNA samples was tested using a no-RT control supermix. qPCR was followed with iTaq Universal Probes Supermix (Bio-Rad) and a Taqman Gene Express Assay (Applied Biosystems) for genes including Zbtb20 (Mm00457765_m1),
, and Slc12a3 (Mm00490213_m1), and Ubc (Mm01201237_m1) as the reference gene. Three randomly chosen no-RT control and 1 nontemplate control were included for each qPCR run in the Mastercycler RealPlex4 system (Eppendorf) with the following protocol: denaturing at 95°C for 30 seconds and 40 cycles at 95°C for 15 and 60°C for 60 seconds. Relative gene expression was analyzed using the Delta-Delta quantification cycle (ΔΔCq) method, and fold changes were calculated between immunized and age-matched naive mice [16] .
Statistical Analysis
Data are presented as means with standard errors of the mean. The statistical significance of differences between groups was determined using Student t test or 1-way analysis of variance followed by Tukey multiple-comparison test. For correlation analysis, Pearson correlation coefficients (r) were calculated from the mean values of each strain. Statistical analyses were conducted with GraphPad Prism 6 software (GraphPad Software).
Multiple testing correction thresholds in Manhattan plots were determined by performing Bonferroni correction of significant (P < .05) P values for the effective number of tests as determined with simpleM [17] . This principal component-based approach gives an estimate of the actual number of tests for association after accounting for nonvariant sites and variants in total linkage disequilibrium.
RESULTS
Serology by ELISA
The mice developed robust antibody titers to the vaccine antigens, with 1 exception as detailed below. There was significant variation in IgG titers between mouse strains determined at week 14 (2 weeks after the third vaccination) (P < .001), but the degree of variation varied for the 4 vaccine antigens. The anti-PT titers varied relatively little, with about a 0.6-log difference between the highest-and lowest-producing strains ( Figure 1B) . The variation in anti-FHA and anti-DT titers was larger, about 1 log, and the largest variation (about 1.5 log) was observed for the anti-Prn titers ( Figure 1A, 1C, and 1D ). PWK/PhJ mice had no detectable anti-Prn IgG antibody at the cutoff threshold of 800 U/mL, but they developed high titers against the other vaccine antigens, especially FHA. When the mean week 14 antibody titers of each strain was plotted for the different vaccine antigens ( Supplementary  Figure 1) , there was a modest correlation between the titers against DT and each of the 3 pertussis antigens, and a weak correlation between the antibody titers against the 3 pertussis antigens.
The antibody titer declined from week 14 to week 24 (2 and 12 weeks after the last injection), with substantial variation between mouse strains (P < .001) (Figure 2 ). There was a Figure 1 . Magnitude of immunoglobulin (Ig) G response to diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine antigens in inbred mouse strains. Total IgG antibody titer measured at week 14 (2 weeks after the third vaccination) against 4 antigens in the DTaP vaccine represents antibody magnitude. Antibody titer was determined by enzyme-linked immunosorbent assay with comparison to a hyperserum standard (100 000 U/mL) obtained in our laboratory and presented here after log transformation. There was significant variation (P < .001 by 1-way analysis of variance) between the antibody magnitude from 28 strains of mice for diphtheria toxoid (DT) (A), pertussis toxin (PT) (B), filamentous hemagglutinin (FHA) (C), and pertactin (Prn) (D). Mouse strains are presented in alphabetical order.
significant correlation between the longevity of the antibodies against DT and the 3 pertussis antigens (Figure 3 ). Unlike antibody magnitude, a moderate to strong correlation was present between the longevities of antibodies to the 3 pertussis antigens (Figure 3 ). The strongest correlation was observed between the longevities of the anti-FHA and anti-Prn titers (r = 0.927).
The avidity of the antibody response to the 4 vaccine antigens at 14 weeks of age showed significant variation between mouse strains (P < .001 for FHA, DT, PT, and Prn; Figure 4 ). The anti-FHA antibodies had the highest avidity, followed by PT, Prn, and DT (Figure 4 ). There was no significant correlation between the antibody avidity for the 4 vaccine antigens (Supplementary Figure 2) . Comparison of these antibody phenotypes against the same antigen showed no correlation between antibody magnitude and avidity, antibody longevity and avidity, or antibody magnitude and longevity (Supplementary Figure 3) .
We included Toll-like receptor (TLR) 4-deficient C3H/HeJ and TLR4-sufficient C3H/HeOuJ mice in our panel to determine a possible effect of TLR4 signaling on the antibody response to DTaP. There was no difference in antibody avidity, but C3H/HeJ mice produced significantly higher antibody titers than C3H/ HeOuJ mice against all 4 vaccine antigens tested ( Figure 1, 4 and Supplementary Figure 4) . The longevity of the anti-DT IgG antibody was less in C3H/HeJ mice, but there was no significant difference in longevity for the pertussis antigen-specific IgG titers (Figure 2 and Supplementary Figure 4) .
Genetic Association Testing and Identification of Candidate Genes
The top 200 SNPs associated with each antibody phenotype were determined using GEMMA analysis (Supplementary Table 2) , also shown as Manhattan plots for longevity ( Figure 5 ), magnitude (Supplementary Figure 5) , and avidity (Supplementary Figure 6) . Because PWK/PhJ did not produce antibody against Prn, this strain was removed from association testing for magnitude, longevity, and avidity against Prn.
Owing to the complex population structure and resultant large stretches of linkage disequilibrium in inbred mouse strains, SNPs associated with a phenotype may in fact act as Figure 2 . Longevity of antibody to diphtheria and tetanus toxoids and acellular pertussis antigens after vaccination. The antibody longevity was defined as the log 10 ratio of total immunoglobulin (Ig) G titers (week 24/ week 14). There was a significant difference among mouse strains (P < .001 by 1-way analysis of variance) for antibody longevity against diphtheria toxoid (DT) (A), pertussis toxin (PT) (B), filamentous hemagglutinin (FHA) (C), and pertactin (Prn) (D). Mouse strains are presented in alphabetical order. Data were included for all mouse strains except DBA/1J, owing to the lack of longevity data for this strain. Correlation of antibody longevity against diphtheria and tetanus toxoids and acellular pertussis antigens. Pearson correlations of longevity (mean value of each strain) between antigens were all significant (ranging from P < .05 to P < .001). Data were included for all mouse strains except DBA/1J, owing to the lack of longevity data for this strain. Abbreviations: DT, diphtheria toxoid; FHA, filamentous hemagglutinin; Prn, pertactin; PT, pertussis toxin. tag SNPs for causative polymorphisms located up to several million base pairs away [15, 18] . To detect potential causative genes in these large regions of linkage disequilibrium, we prioritized genes within 1 million base pairs of the top 200 associated variants for each phenotype containing nonsynonymous SNPs with a PolyPhen probability between 0.95 and 1 (prediction of "probably damaging"). Prioritized genes for each antigen are summarized in Supplementary Table 3 . Venn diagrams illustrate the overlapping gene numbers for each phenotype ( Figure 6 ). For antibody magnitude (week 14 titer), 10 genes were in common for antibodies against DT and PT ( Figure 6A ). For antibody longevity, we identified genes common for longevity of IgG to 2 antigens, namely, DT and PT (29 genes), DT and FHA (11 genes), DT and Prn (14 genes), PT and Prn (11 genes), and FHA and Prn (9 genes) ( Figure 6B ). One gene was shared by DT, PT, and Prn, and 6 were common for all 4 antigens ( Figure 6B ). The 6 common genetic markers identified for longevity are Ap3s1-ps2, Adgrg5, Katnb1, Kifc3, Polr2c, and Slc12a3. For antibody avidity, 25 genes were shared between DT and FHA, and 29 between PT and FHA ( Figure 6C ).
Expression of Candidate Genes for Longevity
Because Ap3s1-ps2 is a pseudogene, it was eliminated from the follow-up analysis of gene expression. The expression of common genes related to longevity was examined in draining and nondraining lymph nodes from mouse strains with long (BALB/cJ and 129S1/SvImJ) and short (SJL/J and LP/J) longevity (Supplementary Table 4 ). The lymph nodes were collected at 1 and 7 days after the third vaccination. These time points were based on preliminary data of gene expression of Zbtb20 and Tnfrsf1,7 which are related to antibody longevity [19, 20] and antibody magnitude [21, 22] , respectively. Increased expression of Tnfrsf17 was observed 7 days after the first and third vaccinations, but a significantly increased expression of Zbtb20 was observed only after the third and not after the first vaccination (Supplementary Figure 7) . qPCR detected no signal from no-RT and nontemplate control controls, except for the primer/probe set of Polr2c, which amplified signals from residual genomic DNA, although the mean Cq value of no-RT controls was significantly higher than that from cDNA samples (data not shown). The reverse transcription qPCR data showed significantly different expression levels for Adgrg5, Polr2c, and Slc12a3 among mouse strains, mostly 1 day after the third vaccination (Figure 7) . However, the expression levels of these genes and that of Zbtb20 did not correlate with the longevity phenotype in the mouse strains ( Figure 7 and Supplementary Figure 8) . Tnfrsf17 was most highly expressed in SJL/J mice at both 1 and 7 days after the third vaccination (Supplementary Figure 8) . This correlates with the fact that SJL/J mice also had the highest IgG antibody titer at week 14. We confirmed that SJL/J mice are the highest responders among the 4 strains tested in an independent experiment (Supplementary Figure 9) .
DISCUSSION
In the current study, we applied a mouse GWAS to identify genetic determinants of the IgG response to pertussis vaccination. Mouse GWASs have several advantages compared with human studies: the experiments can be carried out much more in using relatively small numbers of mice with a defined genotype in a controlled pertussis-free environment, using standardized procedures. In the current study, we measured IgG responses, including the titer 2 weeks after the last vaccination (magnitude), longevity, and the quality (avidity) of antibodies Figure 7 . The expression of genes related to longevity by quantitative reverse transcription polymerase chain reaction (RT-qPCR) in mouse strains with long (BALB/c (Bc) and 129S1/SvImJ (129)) and short (SJ/L and LP/J) longevity. Five common genes (Ap3s1-ps2 is a pseudogene and was not included) were examined for expression in draining (iliac) lymph nodes (iLN) and nondraining (axillary) lymph nodes (aLN) by real-time qPCR at 1 (V3D1) and 7 (V3D7) days after the third vaccination. The delta-delta quantitative cycle (ΔΔCq) values were compared using 1-way analysis of variance and Tukey multiple-comparison tests. Experimental groups identified with different symbols differed significantly from each other (P < .05).
after multiple vaccinations. The serum antibody titers were determined with ELISA, which does not assess the functionality of the antibodies. Nevertheless, several studies have suggested that IgG titers as determined by ELISA are correlated with protection against pertussis in humans [23] [24] [25] .
The large differences in the immune responses among mouse strains indicate that genetic variability contributes significantly to the magnitude, longevity, and avidity of anti-pertussis responses. However, these antibody parameters were not significantly correlated; for example, a high PT antibody titer does not mean that the PT antibody level is sustained longer or that the avidity is higher. Interestingly, comparison of antibody responses to DT, PT, FHA, and Prn revealed stronger correlations for longevity than for magnitude and avidity, suggesting that different mechanisms drive the longevity, magnitude, and avidity of the IgG response. There is a similar large variation in the magnitude, avidity, and half-life of antibodies to PT, FHA, and Prn in humans after vaccination [6, 26, 27] . Our studies suggest that genetic variability is a significant factor contributing to this variation among vaccinated individuals.
PWK/PhJ mice failed to generate a detectable antibody response to Prn despite strong responses to the other vaccine antigens. Such a selective deficiency in antibody response is reminiscent of the lack of antibody response to hepatitis B surface antigen (HBsAg) in a small percentage of individuals vaccinated against hepatitis B. The nonresponsiveness to HBsAg has been linked with certain HLA haplotypes, but the exact mechanism is not known [28] . The lack of HBsAg-specific antibodies is associated with a lack of antigen-specific T cell response, but there is no evidence of a defect in antigen presentation [29, 30] . PWK/PhJ mice are wild-derived mouse strains that add considerable genetic diversity to mouse genetic studies [31] . Limited information is available concerning their immune system. One report indicates that B cells from PWK/Pas mice are hyporesponsive to several TLR agonists, but the mice did have an intact response to protein antigens formulated with complete Freund adjuvant [32] .
Although inbred strains are useful and readily available tools for genetic studies, their complex population structure requires statistical correction [33, 34] . We chose to use GEMMA for association testing, because it uses a linear mixed-model approach originally designed for inbred strains [14, 29] . Unfortunately, this approach can also result in a loss in power, and results do not always meet genome-wide significance [15, 35] . As seen in our study, only 1 trait (antibody magnitude for FHA) had associations that met genome-wide significance after multiple testing correction. Approaches to decrease the risk of false-positives include combining inbred strain genome-wide scans with other genetic data, such as linkage studies or human association studies [13, 31] . No human association studies have been conducted to evaluate DTaP vaccine response, so we chose to identify genes in our study that seemed to contribute to multiple phenotypes, as supporting evidence that these results were not spurious. To do this, we chose the top 200 associations from each study, identified surrounding genes that contain deleterious mutations, and looked for genes that were associated with multiple phenotypes. Because our understanding of the effects of coding variation is much better than noncoding variation, we chose to focus on nonsynonymous coding variants in these large regions to narrow our choice of candidate genes.
Molecules that are involved in stimulating more long-lived plasma cells and maintaining their life span are probably the main determining factors for antibody longevity after vaccination [36] . Although the nature of the vaccine probably plays a crucial role in determining the longevity of the immune response, it is a fixed parameter in the current study and hence did not contribute to the variation we noted in antibody persistence. Zbtb20 has been identified as an intrinsic transcription factor essential for long-term survival of plasma cells [19, 20] . Zbtb20 is necessary to sustain plasma cells that are generated with aluminum-adjuvanted antigen but is not required for the support of plasma cells produced with antigen adjuvanted with TLR agonists [20] . This points to unidentified intrinsic factors responsible for an alternative pathway to imprint the plasma cells when they are formed in the germinal centers. Besides intrinsic factors, signals for building successful niches in the bone marrow for long lived plasma cells may also contribute to the longevity of the antibody response [37] .
In the last part of our studies, we examined the expression of genes we identified as the common genes for antibody longevity, but we did not find consistent correlations between the level of the gene expression and the longevity. There are several possible explanations. First, the common genes we identified for longevity are genes associated with this phenotype and are not necessarily the causality genes. Second, the common genes could have functional roles that are not related to expression levels. Third, we examined gene expression in the draining lymph nodes, and the expression may be different in the bone marrow or other tissues that serve as niches for plasma cell survival.
We included in our study TLR4-deficient C3H/HeJ and TLR4-sufficient C3H/HeOuJ mice to determine whether TLR4 signaling affects the antibody response. A small human cohort study suggested that a TLR4 polymorphism has a negative effect on the antibody response to an acellular pertussis booster in adolescents [38] . Furthermore, TLR4 deficiency had no effect on antibody against PT, FHA, and Prn or decreased antibody against a B. pertussis sonicate after immunization of mice with an acellular pertussis vaccines [39, 40] . In our study, TLR4-deficient C3H/HeJ mice developed higher IgG titers against DT and the 3 pertussis antigens than C3H/HeOuJ mice. The absence of TLR4 did not affect the avidity and decreased the longevity only of the DT-specific IgG, but not of antibodies against PT, FHA, or Prn.
The different effects of TLR4 deficiency reported herein and in the literature probably reflect differences in the route of immunization, dose, and vaccine formulation, because the previous reports used intraperitoneal and subcutaneous injections and a larger vaccine dose [39, 40] . In addition, genetic differences in the TLR4-sufficient strains used as a control (C3H/HeN vs C3H/ HeOuJ) may contribute to the observed differences [41] .
In summary, we applied a mouse GWAS to unravel the genetic basis for the antibody response to DTaP vaccination and found common determinant genes associated with antibody longevity. This finding could lead to new genetic markers for antibody longevity in human beings and provide insight into the mechanisms that regulate antibody longevity.
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